Chemotherapy induced infusion phlebitis

IVTEAM Infusion Phlebitis

“Peripheral epirubicin administration will result in severe CIP being experienced by a proportion of patients irrespective of whether infusion pump or manual injection method is used” Williams et al (2023).

Infusion-related phlebitis reduction

IVTEAM Infusion Phlebitis

“Here we review the major etiologies of IRP and describe potential pharmacological and nonpharmacological interventions for preventing and managing the condition as well as for improving vascular access health in multiple-drug administration settings” Johnson et al (2023).

Biofilm-associated candidal PICC infection – Full Text

CLABSI

“Blood culture detected Candida albicans and plain computed tomography (CT) revealed gas production surrounding the catheter in the brachiocephalic vein (Fig. 1a), leading to a diagnosis of central line-associated candidemia” Fukushima et al (2023).

Chemotherapy infusion phlebitis study

IVTEAM Infusion Phlebitis

“Platinum and cyclophosphamide are commonly associated with phlebitis which can be managed by topical heparin plus benzyl nicotinate. Phlebitis shouldn’t be ignored as it has a high incidence, affects the quality of life, and increases the treatment burden” Sudhakar et al (2023).

Amiodarone-induced phlebitis – Full Text

iv complications

“A large proportion of the patients developed amiodarone-induced phlebitis. The adherence to the clinical practice guideline was not optimal according to the PIVC recommendations” Brørs et al (2023).

Peripheral IV phlebitis risk factors – Full Text

iv complications

“Risk factors for phlebitis involved intrinsic and extrinsic factors to the patient, indicating preventive nursing interventions such as promoting patient mobility, not catheterizing veins in the dorsal arch of the hand, cautious infusion of risk drugs, and valuing pain complaints” Simões et al (2022).